The UK life sciences sector will main- tain its strong growth trajectory, despite investment market normalisation since the 2021 boom.

CBRE estimates that the United Kingdom’s life sciences “golden triangle” of Cambridge, London and Oxford has a combined 10 million square feet (930,000 square metres) of real estate that will be created in the next five years. In its Trends that transcend the US-UK life sciences industry report, it says that venture capital investment has more than doubled into the sector in the past five years, with 80 percent of venture capital funding being allocated to the golden triangle in 2021.

Outside the golden triangle, the consultancy says there is a clear opportunity for investors to capitalise on venture capital investment into emerging hubs such as Stevenage, Manchester, Edinburgh and Birmingham. In 2021, companies in Stevenage received over £200 million (€232 million) in venture capital funding, making it the largest rec